Literature DB >> 3772418

Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience.

C A Presant, W O Russell, R W Alexander, Y S Fu.   

Abstract

Histopathologic peer review of specimens from 216 consecutive patients with soft-tissue or bone sarcomas on Southeastern Cancer Study Group protocols was performed by a panel of three pathologists. Subtype of sarcoma, degree of confidence in diagnosis, and grade were compared with agreement or disagreement in pathologic opinion from the primary member institution v the pathology review panel. The most common soft-tissue sarcoma was leiomyosarcoma, followed by malignant fibrous histiocytoma, fibrosarcoma, liposarcoma, malignant schwannoma, and rhabdomyosarcoma. There was total agreement between the primary pathologist and reviewer in 66% of cases. However, 12 cases (6%) were considered on review to not be sarcomas. In 27% of cases the subtype of sarcoma was felt to be incorrect by reviewers. Discordant diagnoses were more common when the confidence of the pathologist was less and when the tumor was of higher grade. There was no improvement in frequency of agreement in the second half of the study, despite educational workshops. We conclude that histologic peer review is important in sarcoma studies and is essential in many patients with presumed sarcomas.

Entities:  

Mesh:

Year:  1986        PMID: 3772418     DOI: 10.1200/JCO.1986.4.11.1658

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  30 in total

1.  Leiomyosarcoma of the skull base-a diagnostic challenge.

Authors:  J S May; O D Wiestler; U Fisch
Journal:  Skull Base Surg       Date:  1992

2.  Routine screening pelvic examinations have a negative effect on patients.

Authors:  Robert W Shepherd
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

Review 3.  Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance.

Authors:  David L Raunig; Annette M Schmid; Colin G Miller; Richard C Walovitch; Michael O'Connor; Klaus Noever; Ivalina Hristova; Michael O'Neal; Guenther Brueggenwerth; Robert R Ford
Journal:  Ther Innov Regul Sci       Date:  2021-07-09       Impact factor: 1.778

4.  Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma.

Authors:  C Turc-Carel; P Dal Cin; J Limon; U Rao; F P Li; J M Corson; R Zimmerman; D M Parry; J M Cowan; A A Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Soft tissue sarcomas of the extremities and trunk in the adult. Report of 124 cases.

Authors:  C Zornig; H J Weh; A Krüll; R Schwarz; R E Hilgert; S Schröder
Journal:  Langenbecks Arch Chir       Date:  1992

6.  Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database.

Authors:  Andrea Ferrari; Iyad Sultan; Tseng Tien Huang; Carlos Rodriguez-Galindo; Ahmad Shehadeh; Cristina Meazza; Kirsten K Ness; Michela Casanova; Sheri L Spunt
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

Review 7.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

8.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

9.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

10.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.